XSPR.L
Xtrackers MSCI Europe Materials Screened UCITS ETF 1C
Europe
EQUITY
Rules-Based
MANAGEMENT STYLE
£ 3.5 B
ASSETS UNDER MGMT
17 bp
EXPENSES
Fund Basics
| Inception date | Jun 26, 2007 |
| Regulation | UCITS |
| Fund Website | link... |
| Distributions | |
| Currency | GBp |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| AIR LIQUIDE SA | 21.8 % |
| HOLCIM LTD-REG | 10.1 % |
| ANGLO AMERICAN PLC | 10.0 % |
| GIVAUDAN-REG | 7.5 % |
| HEIDELBERGCEMENT AG | 7.3 % |
| SIKA AG-BR | 5.9 % |
| NOVOZYMES A/S-B SHARES | 4.7 % |
| ANTOFAGASTA PLC | 3.9 % |
| BOLIDEN | 3.7 % |
| UPM-KYMMENE OYJ | 3.0 % |
Constituent Breakdown
| Number of holdings | 23 |
| Herfindahl-Hirschman Index | 928 |
| Wgt avg mkt cap (mns) | $48,132 |
| Large cap (>$10bn) | 87.5% |
| Mid cap ($2-10bn) | 5.7% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 100.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
SWITZERLAND | 27.4 % |
 |
FRANCE | 21.8 % |
 |
BRITAIN | 18.4 % |
 |
GERMANY | 10.5 % |
 |
SWEDEN | 5.9 % |
 |
DENMARK | 4.7 % |
 |
FINLAND | 4.5 % |
 |
NETHERLANDS | 2.4 % |
 |
NORWAY | 2.4 % |
 |
BELGIUM | 1.3 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.8% | 13.6% | 7.7% | 8.7% | 5.8% | 15.0% | -- | 4.0% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | 0.0% |
| Total Returns | 7.8% | 13.6% | 7.7% | 8.7% | 5.8% | 15.0% | -- | 4.0% | Ann. Volatility | 16.8% | 27.1% | 23.6% | 22.7% | 23.5% | 29.1% | -- | 36.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.18 | 2% |
| MSCI EAFE | 0.41 | 6% |
| MSCI Emg Mkts | 0.33 | 5% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $15,043.85 |
| Relative strength (RSI) | 60 |
| MACD/Signal | 214.69/186.93 |
| Bollinger Bands (Upper/Lower) | $15,695.00/$14,571.10 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XSPR.L |
Expenses vs. XSPR.L |
ALTAR Score™ vs. XSPR.L |
|---|---|---|---|---|
| EXV7.DE | iShares STOXX Europe 600 Chemicals UCITS ETF (DE) | 35.9% | +29 bp | +0.4% |
| EXV8.DE | iShares STOXX Europe 600 Construction & Materials UCITS ETF | 22.7% | +29 bp | +0.7% |
| EXV6.DE | iShares STOXX Europe 600 Basic Resources UCITS ETF (DE) | 20.1% | +29 bp | +2.1% |
| WMTS.AS | iShares MSCI World Materials Sector Advanced UCITS ETF | 17.3% | +1 bp | -0.3% |
| XDWM.DE | Xtrackers MSCI World Materials UCITS ETF 1C | 17.1% | +8 bp | -0.5% |
| WELI.DE | Amundi S&P World Materials Screened UCITS ETF Acc | 12.8% | +1 bp | -0.7% |
| WELV.DE | Amundi S&P World Materials Screened UCITS ETF Dist | 12.8% | +1 bp | -0.7% |
| DMAT.L | Global X Disruptive Materials UCITs ETF | 11.3% | +33 bp | -0.7% |
Risk and Returns: XSPR.L vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (GBP)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.6%
ALTAR SCORE™
11st
PERCENTILE
AVOID
ETFRC RATING
There are 239 funds in the Europe Equity category with an average
ALTAR Score™ of 7.2% and a standard deviation
of 1.3%. XSPR.L's ALTAR Score™ is approximately -1.2 standard
deviations above the category average. This places XSPR.L in the 11st percentile
among funds in the category.
Sell-Side Consensus
£16987.7
PRICE TARGET
+18.5%
UPSIDE